Skip to main content

Chapter 23: Food allergy

Buy Article:

$31.50 plus tax (Refund Policy)

The onset of IgE-mediated food allergy is usually within minutes to 2 hours of food ingestion. Risk factors for fatal food-induced anaphylaxis include presence of asthma (which is a risk factor for anaphylaxis in general), failure to use epinephrine autoinjectors promptly, history of prior severe reactions, known food allergy, denial of symptoms, and adolescent/young adult age. The most commonly implicated foods are cow's milk, eggs, peanuts, soy, tree nuts, fish, shellfish, and wheat. Allergies to peanut, tree nuts, and seafood are the most common food allergens in adults. The major food allergens are glycoproteins that are generally water soluble and stable to the effects of heat, proteases, and acids. Food proteins that escape proteolysis are taken up by intestinal epithelial cells and presented to primed T cells. This process leads to the generation of T-helper type 2 (Th2) cells that produce IL-4, IL-5, and IL-13. Recent studies have found that tolerance can be acquired with >70% of children becoming tolerant to cow's milk and eggs by age 16 years. Allergies to peanuts, tree nuts, and seafood are frequently lifelong. Food-allergic patients or their care givers should be taught when and how to administer injectable epinephrine. In terms of prevention, the American Academy of Pediatrics concluded that there is no convincing evidence that delaying the introduction of solid foods, including common allergens, beyond 4‐6 months of age has a protective effect on the development of atopic disease.
No Reference information available - sign in for access.
No Citation information available - sign in for access.
No Supplementary Data.
No Article Media
No Metrics

Keywords: Anaphylaxis; IgE-mediated food allergy; egg; epinephrine autoinjectors; peanut; prevention; risk factors; tolerance

Document Type: Research Article

Publication date: 2012-05-01

More about this publication?
  • Allergy and Asthma Proceedings is a peer reviewed publication dedicated to distributing timely scientific research regarding advancements in the knowledge and practice of allergy, asthma and immunology. Its primary readership consists of allergists and pulmonologists.

    The goal of the Proceedings is to publish articles with a predominantly clinical focus which directly impact quality of care for patients with allergic disease and asthma.

    Featured topics include asthma, rhinitis, sinusitis, food allergies, allergic skin diseases, diagnostic techniques, allergens, and treatment modalities. Published material includes peer-reviewed original research, clinical trials and review articles.

    Articles marked "F" offer free full text for personal noncommercial use only.

    The journal is indexed in Thomson Reuters Web of Science and Science Citation Index Expanded, plus the National Library of Medicine's PubMed service.
  • Editorial Board
  • Information for Authors
  • Submit a Paper
  • Information for Advertisers
  • Reprint Requests
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more